Replimune (REPL) Total Liabilities (2018 - 2025)

Replimune has disclosed Total Liabilities across 8 years of filings, most recently posting $123.1 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $123.1 million, up 1.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $123.1 million (up 1.48% YoY), and the FY2025 annual result was $135.5 million, up 19.67% from the prior year.
• Total Liabilities came in at $123.1 million for Q4 2025 at Replimune, down from $126.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $135.5 million in Q1 2025 to a low of $44.4 million in Q1 2021.
• The 5-year median for Total Liabilities is $94.3 million (2023), against an average of $89.2 million.
• Across the five-year window, Total Liabilities declined 13.65% in 2021 and surged 86.89% in 2023, its largest moves.
• Replimune's Total Liabilities stood at $47.8 million in 2021, then soared by 74.17% to $83.2 million in 2022, then jumped by 33.88% to $111.4 million in 2023, then climbed by 8.85% to $121.3 million in 2024, then increased by 1.48% to $123.1 million in 2025.
• The last three Total Liabilities figures came in at $123.1 million (Q4 2025), $126.1 million (Q3 2025), and $132.8 million (Q2 2025), per Business Quant data.